Article and Video CATEGORIES
Dr. Karen Kelly of University of California, Davis, presents her current view on using molecular markers in early stage non-small cell lung cancer and explains the RADIANT study that she leads.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Janine, thank you so much for your kind response. It definitely brought some clarity during this uncertain time for my father. He's scheduled for the first infusion next Tuesday with...
We're glad to help. The link in my previous post (at "2nd opinion". sorry I didn't even point it out) is a most excellent article to answer your questions so I...
Hi snickerdoodle, I'm sorry you're going through this worry. Cea levels for nsclc don't really inform treatment decisions. They sometimes forewarn the coming of progression but sometimes progression doesn't follow a...
I appreciate the comments. I also want to correct my mistake in CEA level- I forgot the decimal. In the past year, my level has increased from 4.7 to 28.3, NOT...
Hi Rick and welcome to Grace. I'm sorry you're going through this. Ethically or legally we can't comment on reports.
Cancer and infection look alike on film and they both cause...
Hi szhang, I'm so sorry to know that your father is in this position.
It's not known if your father would have progressed in the same way whether he stayed on...